Redmile Group Is Putting More Money Into Array BioPharma Inc. (ARRY)
Jeremy Green’s Redmile Group has just acquired more shares of Array BioPharma Inc. (NASDAQ:ARRY). In a Form 4 filed with the U.S.
Array Technologies Inc. (ARRY)
Market is closed
News
- First
- << Previous
- 91 - 100
- Next >>
One Of Mark Lampert's Small-Cap Biotech Picks Has Returned 84% This Year And It's Not Done Yet
Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31.
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
At the moment, there are plenty of metrics investors can use to track their holdings. Two of the most under-the-radar are hedge fund and insider trading interest.
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most innovative are hedge fund and insider trading sentiment.
Array Biopharma Inc (ARRY), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Ways Your Kids Can Be Harmed by Smog
Around four in 10 Americans live in places where smog can impact their health. Children and teens are especially vulnerable to higher levels of ozone in the air associated with smog.
Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market.
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week
The study included 184 patients with mild-to-moderate persistent allergic asthma. ARRY-502 met the study's primary endpoint of significant improvement in a key measure of lung function.
- First
- << Previous
- 91 - 100
- Next >>
Billionaire Hedge Funds
